XML 26 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

Capital Stock and Changes in Capital Accounts | 6 Months Ended
--- | ---
Jun. 30, 2026
Capital Stock and Changes in Capital Accounts [Abstract] |
Capital Stock and Changes in Capital Accounts | 10. Capital Stock and Changes in Capital Accounts a) Preferred stock : As of June 30, 2026, and December 31, 2025, the Company’s authorized preferred stock consists of 50,000,000 shares (all in registered form), par value $ 0.01 per share, of which 1,000,000 shares are designated as Series A Participating Preferred Shares, 5,000,000 shares are designated as Series B Preferred Shares, 10,675 shares are designated as Series C Preferred Shares and 400 shares are designated as Series D Preferred Shares. As of June 30, 2026 and 2025, the Company had zero Series A Participating Preferred Shares issued and outstanding. b) Series B Preferred Stock: As of June 30, 2026, and December 31, 2025, the Company had 2,600,000 Series B Preferred Shares issued and outstanding with par value $ 0.01 per share, at $ 25.00 per share and with liquidation preference at $ 25.00 per share. Holders of Series B Preferred Shares have no voting rights other than the ability, subject to certain exceptions, to elect one director if dividends for six quarterly dividend periods (whether or not consecutive) are in arrears and certain other limited protective voting rights. Also, holders of Series B Preferred Shares rank prior to the holders of common shares with respect to dividends, distributions and payments upon liquidation and are subordinated to all of the existing and future indebtedness. Dividends on the Series B Preferred Shares are cumulative from the date of original issue and are payable on the 15th day of January, April, July and October of each year at a dividend rate of 8.875 % per annum, or $ 2.21875 per share per annum. For the six months ended June 30, 2026 and 2025, dividends on Series B Preferred Shares amounted to $ 2,884 . Since February 14, 2019, the Company may redeem, in whole or in part, the Series B Preferred Shares at a redemption price of $ 25.00 per share plus an amount equal to all accumulated and unpaid dividends thereon to the date of redemption, whether or not declared. c) Series C Preferred Stock : As of June 30, 2026, and December 31, 2025, the Company had 10,675 shares of Series C Preferred Stock, issued and outstanding, with par value $ 0.01 per share, owned by an affiliate of its Chief Executive Officer, Ms. Semiramis Paliou. The Series C Preferred Stock votes with the common shares of the Company, and each share entitles the holder thereof to 1,000 votes on all matters submitted to a vote of the shareholders of the Company. The Series C Preferred Stock has no dividend or liquidation rights and cannot be transferred without the consent of the Company except to the holder’s affiliates and immediate family members. d) Series D Preferred Stock : As of June 30, 2026, and December 31, 2025, the Company had 400 shares of Series D Preferred Stock, issued and outstanding, with par value $ 0.01 per share, owned by an affiliate of its Chief Executive Officer, Ms. Semiramis Paliou. The Series D Preferred Stock is not redeemable and has no dividend or liquidation rights. The Series D Preferred Stock vote with the common shares of the Company, and each share of the Series D Preferred Stock entitles the holder thereof to up to 200,000 votes, on all matters submitted to a vote of the stockholders of the Company, provided however, that, notwithstanding any other provision of the Series D Preferred Stock statement of designation, to the extent that the total number of votes one or more holders of Series D Preferred Stock is entitled to vote (including any voting power of such holders derived from Series D Preferred Stock, shares of Common Stock or any other voting security of the Company issued and outstanding as of the date hereof or that may be issued in the future) on any matter submitted to a vote of stockholders of the Company would exceed 36.0 % of the total number of votes eligible to be cast on such matter, the total number of votes that holders of Series D Preferred Stock may exercise derived from the Series D Preferred Stock together with Common Shares and any other voting securities of the Company beneficially owned by such holder, shall be reduced to 36 % of the total number of votes that may be cast on such matter submitted to a vote of stockholders. e) Repurchase of Common Shares: On December 2, 2024, the Company commenced a tender offer to purchase up to 15,000,000 shares of its outstanding common stock, at $ 2.00 per share, using funds available from cash and cash equivalents. On January 7, 2025, the tender offer was settled and the Company repurchased and retired a total of 11,442,645 shares of common stock for an aggregate amount of $ 23,048 . f) Dividend on Common Stock: On March 21, 2025, the Company paid a cash dividend on its common stock of $ 0.01 per share, or $ 1,158 , to all shareholders of record as of March 12, 2025. On June 24, 2025, the Company paid a cash dividend on its common stock of $ 0.01 per share, or $ 1,158 , to all shareholders of record as of June 17, 2025. On March 18, 2026, the Company paid a cash dividend on its common stock of $ 0.01 per share, or $ 1,236 to all shareholders of record as of March 11, 2026. On June 18, 2026, the Company paid a cash dividend on its common stock of $ 0.01 per share, or $ 1,244 to all shareholders of record as of June 10, 2026. g) Warrants: On December 14, 2023, the Company distributed 22,613,070 warrants to its shareholders of record on December 6, 2023. Holders received one warrant for every five shares of issued and outstanding shares of common stock held as of the record date (rounded down to the nearest whole number for any fractional warrant. Each Warrant entitles the holder to purchase, at the holder’s sole and exclusive election, at the exercise price of $ 4 per warrant, 1.68852 shares of common stock including a bonus share fraction. A bonus share fraction entitles a holder to receive an additional part of a share of common stock for each warrant exercised without payment of any additional exercise price. The Company's warrants are classified as liabilities and are remeasured at fair value at each reporting date, with changes in fair value recognized in earnings. The warrants are listed on the New York Stock Exchange under the symbol "DSX_W." The fair value of the warrants is determined using quoted market prices in an active market and is classified as a Level 1 measurement within the fair value hierarchy. During the six months ended June 30, 2026 and 2025, the Company issued 876,267 and 12,802 shares, respectively, having a value of $ 2,040 and $ 16 , net of expenses, or $ 2.33 and $ 1.24 per share, respectively. During the six months ended June 30, 2026 and 2025, the Company received $ 2,097 and $ 69 , in proceeds, net of fees from the exercise of 521,143 and 7,825 warrants, respectively. If all warrants were exercised as of June 30, 2026, the Company would have issued 37,221,648 shares of common stock, including the shares from the warrants already exercised, with a fair value of $ 85,733 and would have received $ 90,452 gross proceeds. As of June 30, 2026 and December 31, 2025, the warrant liability amounted to $ 2,352 and $ 1,330 , respectively. During the six months ended June 30, 2026 and 2025, gain/loss on warrants amounted to a loss of $ 1,086 and a gain of $ 515 , respectively, and is separately presented in the accompanying unaudited interim consolidated statements of income. h) Incentive Plan: Effective April 29, 2026, the Company amended and restated its Equity Incentive Plan to increase the aggregate number of shares of common stock that may be delivered pursuant to awards granted under the plan by 50,000,000 common shares. As of June 30, 2026, 51,394,759 shares remained reserved for issuance according to the Company’s incentive plan. Restricted stock as of June 30, 2026 and 2025 is analyzed as follows: Number of Shares Weighted Average Grant Date Price Outstanding as of December 31, 2024 6,097,502 $ 3.30 Granted 2,000,000 1.84 Vested (3,134,365) 3.37 Outstanding as of June 30, 2025 4,963,137 $ 2.67 Outstanding as of December 31, 2025 4,963,137 $ 2.67 Granted 7,750,000 2.59 Vested (2,945,335) 2.99 Outstanding as of June 30, 2026 9,767,802 $ 2.51 The fair value of the restricted shares has been determined with reference to the closing price of the Company’s stock on the date such awards were approved by the Company’s board of directors. The aggregate compensation cost is recognized ratably in the accompanying unaudited interim consolidated statements of income over the respective vesting periods. For the six months ended June 30, 2026 and 2025, compensation cost amounted to $ 3,918 and $ 5,270 , respectively, and is included in general and administrative expenses in the accompanying unaudited interim consolidated statements of income. As of June 30, 2026 and December 31, 2025, the total unrecognized cost relating to restricted share awards was $ 21,904 and $ 5,749 , respectively. As of June 30, 2026, the weighted-average period over which the total compensation cost related to non-vested awards not yet recognized is expected to be recognized is 4.41 years. The total fair value of shares vested during the six months ended June 30, 2026 and 2025 was $ 8,756 and $ 10,584 , respectively.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration